Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-EN Version v4-EN
Language English English
Date Updated 2022-11-12 2021-09-24
Drug Identification Number 02244931 02244931
Brand name MESNA FOR INJECTION MESNA FOR INJECTION
Common or Proper name Mesna for Injection 100 mg/mL MD Vial 10 mL Mesna for Injection 100 mg/mL MD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients MESNA MESNA
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 mL 10 mL
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-08-06 2021-08-06
Actual start date 2021-08-06
Estimated end date 2022-12-01 2021-12-06
Actual end date 2022-11-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Mesna for Injection 100 mg/mL MD Vial 10 mL until December 1, 2022 Fresenius Kabi Canada Ltd. regrets to advise that due to further production. Baxter is an alternate supplier of Mesna for Injection and has been informed of our impending supply interruption.
Health Canada comments